Home/Cyclerion Therapeutics/Regina Graul, PhD
RG

Regina Graul, PhD

President, Chief Executive Officer, Board Member

Cyclerion Therapeutics

Cyclerion Therapeutics Pipeline

DrugIndicationPhase
CYC-126Treatment-Resistant Depression (TRD)Phase 1